Skip to content

Effect of allopurinol on cardiac recovery after myocardial infarction

The impact of Allopurinol use on one-year outcome of patients with acute myocardial infarction undergoing primary Percutaneous Coronary Intervention(PCI)

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20140512017666N2
Enrollment
170
Registered
2019-10-15
Start date
2019-02-20
Completion date
Unknown
Last updated
2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial infarction. ST elevation (STEMI) myocardial infarction of anterior wall

Interventions

Intervention group: 300mg of oral Allopurinol at emergency ward before primary PCI and 100mg per day for one month thereafter.

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients more than 18 years old with chest pain onset less than 12 hours and diagnosed with acute anterior ST-elevation myocardial infarction( STEMI), undergoing successful primary PCI in the Tabriz Madani Heart Center.

Exclusion criteria

Exclusion criteria: Ventricular tachycardia,ventricular fibrilation,complete heart block,copmlete LBBB(Left Bundle Branch Block), /RBBB(Right Bundle branch Block) at admission Previous MI , heart failure or previous revascularization(PCI or Coronary artery bypass graft) Severe valvular heart disease Current allopurinol users Contraindications to allopurinol use Patients who have undergone "only ballon angioplasty" due to inappropriate coronary anatomy for stenting Cardiogenic shock,heart failure with killip class 2 or higher at admission Previous stroke or stroke at admission Abnormal uric acid levels above upper limit of normal

Design outcomes

Primary

MeasureTime frame
Intra Hospital Major Adverse Cardiovascular Events(MACE). Timepoint: Hospitalization Period. Method of measurement: Number of Major adverse cardiac events including death and acute heart failure.;Ischemic stroke. Timepoint: 1, 6 and 12 months after discharge. Method of measurement: Documented past medical history.;Heart failure. Timepoint: 1, 6 and 12 months after discharge. Method of measurement: clinical evidence of Heart failure via questionaire.;Mortality. Timepoint: 1, 6 and 12 months after discharge. Method of measurement: Questionaire.

Secondary

MeasureTime frame
ST resolution >50 %. Timepoint: Admission to emergency room, 90 minutes after primary Percutaneous Coronary Intervention(PCI). Method of measurement: Electrocardiography.;Left ventricular ejection fraction. Timepoint: Admission, before discharge, one month after discharge. Method of measurement: Echocardiography.;Left ventricle end diastolic diameter. Timepoint: Admission, before discharge, one month after discharge. Method of measurement: Echocardiography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Separham

Tabriz University of Medical Sciences

separham@tbzmed.ac.ir+98 41 3337 3900

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 5, 2026